On April 4, 2024, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued the preliminary opinion (SCCS/1664/24) on Triphenyl phosphate (CAS No.115-86-6, EC No.204-112-2). The deadline for comments is set for 2 June 2024.

On April 4, 2024, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued a final opinion on Benzophenone-4(SCCS/1660/23). The preliminary opinion was released on December 15, 2023.

On March 29, 2024, China’s National Institutes for Food and Drug Control released the "Guidelines for Submission of Cosmetic Safety Assessment Information for public comments. Based on the principles of risk management, the "Guidelines for Submission of Cosmetic Safety Assessment Information (Draft for Comment)" classifies the scenarios for the submission of cosmetic safety assessment data; it also establishes key points for self-inspection of cosmetic safety assessment reports to guide enterprises in conducting product safety evaluations.

On April 3, 2024, the European Commission issued Regulation (EU) 2024/996, amending the EU Cosmetics Regulation (EC) No 1223/2009

We have collected the latest FAQs on ordinary cosmetics filing from Beijing Cosmetics Review and Inspection Center and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

On February 10, 2023, the first part of the Canadian Gazette announced the revision to the Canadian Cosmetic Regulations to strengthen the regulation of cosmetics in Canada.

FDA Direct is a U.S. Food and Drug Administration's web-based and free structured product labeling (SPL) authoring tool. Previously CDER Direct, FDA Direct now includes CDER Direct and Cosmetics Direct. Users can create separate accounts, depending on drugs or cosmetics submissions, or a single account that includes both CDER Direct submissions as well as Cosmetics Direct submissions.